81_FR_1967 81 FR 1958 - Proposed Collection; 60-Day Comment Request; Self-Affirmation Construct Validity (NCI) [email protected] Formal requests for additional plans and instruments must be requested in writing. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: Self-affirmation Construct Validity, 0925-NEW, National Cancer Institute (NCI), National Institutes of Health (NIH). Need and Use of Information Collection: This information collection, seeks to refine a theory about how self-competence and values play a role in defensive responses to health communications. Although theoretically-driven research has shown that self- affirmation--a process by which individuals reflect on values that are important to them--can improve responses to health and cancer communications, the ``active ingredient'' (or mechanisms underlying effectiveness) of self-affirmations is unknown. Self-affirmation is a potent means of augmenting the effectiveness of threatening health communications. Individuals tend to be defensive against information suggesting their behavior puts them at risk for disease or negative health. Previous evidence suggests that self-affirmation may reduce defensiveness to threatening health information, increasing openness to the message and resulting in increased disease risk perceptions, disease-related worry, intentions to engage in preventive behavior, and actual behavioral change. Understanding the mechanisms that explain these robust effects would yield evidence important for dissemination, including ways to refine self-affirmation interventions and make them more potent, which could change the ways that public health messages are constructed. This research can inform NCI scientific priorities and investments in self-affirmation research. The results of the information collection will be used to further develop and improve self-affirmation theory. These findings may allow future researchers to develop and test cancer prevention interventions. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 717."> [email protected] Formal requests for additional plans and instruments must be requested in writing. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: Self-affirmation Construct Validity, 0925-NEW, National Cancer Institute (NCI), National Institutes of Health (NIH). Need and Use of Information Collection: This information collection, seeks to refine a theory about how self-competence and values play a role in defensive responses to health communications. Although theoretically-driven research has shown that self- affirmation--a process by which individuals reflect on values that are important to them--can improve responses to health and cancer communications, the ``active ingredient'' (or mechanisms underlying effectiveness) of self-affirmations is unknown. Self-affirmation is a potent means of augmenting the effectiveness of threatening health communications. Individuals tend to be defensive against information suggesting their behavior puts them at risk for disease or negative health. Previous evidence suggests that self-affirmation may reduce defensiveness to threatening health information, increasing openness to the message and resulting in increased disease risk perceptions, disease-related worry, intentions to engage in preventive behavior, and actual behavioral change. Understanding the mechanisms that explain these robust effects would yield evidence important for dissemination, including ways to refine self-affirmation interventions and make them more potent, which could change the ways that public health messages are constructed. This research can inform NCI scientific priorities and investments in self-affirmation research. The results of the information collection will be used to further develop and improve self-affirmation theory. These findings may allow future researchers to develop and test cancer prevention interventions. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 717." /> [email protected] Formal requests for additional plans and instruments must be requested in writing. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: Self-affirmation Construct Validity, 0925-NEW, National Cancer Institute (NCI), National Institutes of Health (NIH). Need and Use of Information Collection: This information collection, seeks to refine a theory about how self-competence and values play a role in defensive responses to health communications. Although theoretically-driven research has shown that self- affirmation--a process by which individuals reflect on values that are important to them--can improve responses to health and cancer communications, the ``active ingredient'' (or mechanisms underlying effectiveness) of self-affirmations is unknown. Self-affirmation is a potent means of augmenting the effectiveness of threatening health communications. Individuals tend to be defensive against information suggesting their behavior puts them at risk for disease or negative health. Previous evidence suggests that self-affirmation may reduce defensiveness to threatening health information, increasing openness to the message and resulting in increased disease risk perceptions, disease-related worry, intentions to engage in preventive behavior, and actual behavioral change. Understanding the mechanisms that explain these robust effects would yield evidence important for dissemination, including ways to refine self-affirmation interventions and make them more potent, which could change the ways that public health messages are constructed. This research can inform NCI scientific priorities and investments in self-affirmation research. The results of the information collection will be used to further develop and improve self-affirmation theory. These findings may allow future researchers to develop and test cancer prevention interventions. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 717." />

81 FR 1958 - Proposed Collection; 60-Day Comment Request; Self-Affirmation Construct Validity (NCI)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 9 (January 14, 2016)

Page Range1958-1959
FR Document2016-00545

In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Cancer Institute, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. Written comments and/or suggestions from the public and affected agencies are invited to address one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) The quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. To Submit Comments and for Further Information: To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact*: Rebecca Ferrer, Program Director, Basic Biobehavioral and Psychological Sciences Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 9609 Medical Center Dr., Rockville MD 20852. or call non-toll-free number (240) 276-6914 or Email your request, including your address to: [email protected] Formal requests for additional plans and instruments must be requested in writing. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: Self-affirmation Construct Validity, 0925-NEW, National Cancer Institute (NCI), National Institutes of Health (NIH). Need and Use of Information Collection: This information collection, seeks to refine a theory about how self-competence and values play a role in defensive responses to health communications. Although theoretically-driven research has shown that self- affirmation--a process by which individuals reflect on values that are important to them--can improve responses to health and cancer communications, the ``active ingredient'' (or mechanisms underlying effectiveness) of self-affirmations is unknown. Self-affirmation is a potent means of augmenting the effectiveness of threatening health communications. Individuals tend to be defensive against information suggesting their behavior puts them at risk for disease or negative health. Previous evidence suggests that self-affirmation may reduce defensiveness to threatening health information, increasing openness to the message and resulting in increased disease risk perceptions, disease-related worry, intentions to engage in preventive behavior, and actual behavioral change. Understanding the mechanisms that explain these robust effects would yield evidence important for dissemination, including ways to refine self-affirmation interventions and make them more potent, which could change the ways that public health messages are constructed. This research can inform NCI scientific priorities and investments in self-affirmation research. The results of the information collection will be used to further develop and improve self-affirmation theory. These findings may allow future researchers to develop and test cancer prevention interventions. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 717.

Federal Register, Volume 81 Issue 9 (Thursday, January 14, 2016)
[Federal Register Volume 81, Number 9 (Thursday, January 14, 2016)]
[Notices]
[Pages 1958-1959]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-00545]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Proposed Collection; 60-Day Comment Request; Self-Affirmation 
Construct Validity (NCI)

SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of 
the Paperwork Reduction Act of 1995, for opportunity for public comment 
on proposed data collection projects, the National Cancer Institute, 
the National Institutes of Health (NIH) will publish periodic summaries 
of proposed projects to be submitted to the Office of Management and 
Budget (OMB) for review and approval.
    Written comments and/or suggestions from the public and affected 
agencies are invited to address one or more of the following points: 
(1) Whether the proposed collection of information is necessary for the 
proper performance of the function of the agency, including whether the 
information will have practical utility; (2) The accuracy of the 
agency's estimate of the burden of the proposed collection of 
information, including the validity of the methodology and assumptions 
used; (3) The quality, utility, and clarity of the information to be 
collected; and (4) Minimize the burden of the collection of information 
on those who are to respond, including the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology.
    To Submit Comments and for Further Information: To obtain a copy of 
the data collection plans and instruments, submit comments in writing, 
or request more information on the proposed project, contact*: Rebecca 
Ferrer, Program Director, Basic Biobehavioral and Psychological 
Sciences Branch, Behavioral Research Program, Division of Cancer 
Control and Population Sciences, National Cancer Institute, 9609 
Medical Center Dr., Rockville MD 20852. or call non-toll-free number 
(240) 276-6914 or Email your request, including your address to: 
ferrerra@mail.nih.gov. Formal requests for additional plans and 
instruments must be requested in writing.

[[Page 1959]]

    Comment Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 60 days 
of the date of this publication.
    Proposed Collection: Self-affirmation Construct Validity, 0925-NEW, 
National Cancer Institute (NCI), National Institutes of Health (NIH).
    Need and Use of Information Collection: This information 
collection, seeks to refine a theory about how self-competence and 
values play a role in defensive responses to health communications. 
Although theoretically-driven research has shown that self-
affirmation--a process by which individuals reflect on values that are 
important to them--can improve responses to health and cancer 
communications, the ``active ingredient'' (or mechanisms underlying 
effectiveness) of self-affirmations is unknown. Self-affirmation is a 
potent means of augmenting the effectiveness of threatening health 
communications. Individuals tend to be defensive against information 
suggesting their behavior puts them at risk for disease or negative 
health. Previous evidence suggests that self-affirmation may reduce 
defensiveness to threatening health information, increasing openness to 
the message and resulting in increased disease risk perceptions, 
disease-related worry, intentions to engage in preventive behavior, and 
actual behavioral change. Understanding the mechanisms that explain 
these robust effects would yield evidence important for dissemination, 
including ways to refine self-affirmation interventions and make them 
more potent, which could change the ways that public health messages 
are constructed. This research can inform NCI scientific priorities and 
investments in self-affirmation research. The results of the 
information collection will be used to further develop and improve 
self-affirmation theory. These findings may allow future researchers to 
develop and test cancer prevention interventions.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 717.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Average time
           Form name                Types of         Number of     responses per   per response     Total hour
                                   respondents      respondents     respondent      (in hours)        burden
----------------------------------------------------------------------------------------------------------------
Screener......................  General Public..          10,000               1            1/60             167
Study.........................  General Public..           1,100               1           30/60             550
----------------------------------------------------------------------------------------------------------------


    Dated: January 7, 2016.
Karla Bailey,
Project Clearance Liaison, National Cancer Institute, NIH.
[FR Doc. 2016-00545 Filed 1-13-16; 8:45 am]
BILLING CODE 4140-01-P



                                                  1958                          Federal Register / Vol. 81, No. 9 / Thursday, January 14, 2016 / Notices

                                                  the information at: http://www.fda.gov/                 products with recommendations on how                   default.htm or http://
                                                  regulatoryinformation/dockets/                          to report the labeling changes to FDA                  www.regulations.gov.
                                                  default.htm.                                            under 21 CFR 601.12. Additional                          Dated: January 7, 2016.
                                                     Docket: For access to the docket to                  changes to the guidance include adding                 Leslie Kux,
                                                  read background documents or the                        information in the background section
                                                                                                                                                                 Associate Commissioner for Policy.
                                                  electronic and written/paper comments                   relevant to the new labeling
                                                                                                                                                                 [FR Doc. 2016–00536 Filed 1–13–16; 8:45 am]
                                                  received, go to http://                                 recommendations; providing updated
                                                                                                                                                                 BILLING CODE 4164–01–P
                                                  www.regulations.gov and insert the                      information on the global vCJD and
                                                  docket number, found in brackets in the                 Bovine Spongiform Encephalopathy
                                                  heading of this document, into the                      epidemics; clarifying the reentry criteria
                                                                                                                                                                 DEPARTMENT OF HEALTH AND
                                                  ‘‘Search’’ box and follow the prompts                   for a donor with a family history of CJD;
                                                                                                                                                                 HUMAN SERVICES
                                                  and/or go to the Division of Dockets                    clarifying the requirements related to
                                                  Management, 5630 Fishers Lane, Rm.                      biological product deviation reporting;                National Institutes of Health
                                                  1061, Rockville, MD 20852.                              and, updating, adding, and removing
                                                     Submit written requests for single                   certain footnotes and references. FDA                  Proposed Collection; 60-Day Comment
                                                  copies of the guidance to the Office of                 received four comments on the 2012                     Request; Self-Affirmation Construct
                                                  Communication, Outreach, and                            draft guidance, and those comments                     Validity (NCI)
                                                  Development, Center for Biologics                       were considered in the finalization of
                                                  Evaluation and Research (CBER), Food                    the draft guidance.                                    SUMMARY:   In compliance with the
                                                  and Drug Administration, 10903 New                         This guidance does not address                      requirement of Section 3506(c)(2)(A) of
                                                  Hampshire Ave., Bldg. 71, Rm. 3128,                     potential changes to the geographic                    the Paperwork Reduction Act of 1995,
                                                                                                          exposure based deferrals for risk of                   for opportunity for public comment on
                                                  Silver Spring, MD 20993–0002. Send
                                                                                                          vCJD. FDA discussed such potential                     proposed data collection projects, the
                                                  one self-addressed adhesive label to
                                                                                                          changes with its Transmissible                         National Cancer Institute, the National
                                                  assist the office in processing your
                                                                                                          Spongiform Encephalopathies Advisory                   Institutes of Health (NIH) will publish
                                                  requests. The guidance may also be
                                                                                                          Committee in June 2015 and intends to                  periodic summaries of proposed
                                                  obtained by mail by calling CBER at 1–
                                                                                                          address revised recommendations for                    projects to be submitted to the Office of
                                                  800–835–4709 or 240–402–8010. See
                                                                                                          geographic donor deferrals in future                   Management and Budget (OMB) for
                                                  the SUPPLEMENTARY INFORMATION section
                                                                                                          guidance documents.                                    review and approval.
                                                  for electronic access to the guidance                                                                             Written comments and/or suggestions
                                                  document.                                                  This guidance is being issued
                                                                                                          consistent with FDA’s good guidance                    from the public and affected agencies
                                                  FOR FURTHER INFORMATION CONTACT:                        practices regulation (21 CFR 10.115).                  are invited to address one or more of the
                                                  Tami Belouin, Center for Biologics                      The guidance represents the current                    following points: (1) Whether the
                                                  Evaluation and Research, Food and                       thinking of FDA on Revised Preventive                  proposed collection of information is
                                                  Drug Administration, 10903 New                          Measures to Reduce the Possible Risk of                necessary for the proper performance of
                                                  Hampshire Ave., Bldg. 71, Rm. 7301,                     Transmission of Creutzfeldt-Jakob                      the function of the agency, including
                                                  Silver Spring, MD 20993–0002, 240–                      Disease and Variant Creutzfeldt-Jakob                  whether the information will have
                                                  402–7911.                                               Disease by Blood and Blood Products;                   practical utility; (2) The accuracy of the
                                                  SUPPLEMENTARY INFORMATION:                              Guidance for Industry. It does not                     agency’s estimate of the burden of the
                                                                                                          establish any rights for any person and                proposed collection of information,
                                                  I. Background                                                                                                  including the validity of the
                                                                                                          is not binding on FDA or the public.
                                                     FDA is announcing the availability of                You can use an alternative approach if                 methodology and assumptions used; (3)
                                                  a document entitled ‘‘Revised                           it satisfies the requirements of the                   The quality, utility, and clarity of the
                                                  Preventive Measures to Reduce the                       applicable statutes and regulations.                   information to be collected; and (4)
                                                  Possible Risk of Transmission of                                                                               Minimize the burden of the collection of
                                                  Creutzfeldt-Jakob Disease and Variant                   II. Paperwork Reduction Act of 1995                    information on those who are to
                                                  Creutzfeldt-Jakob Disease by Blood and                     This guidance refers to previously                  respond, including the use of
                                                  Blood Products; Guidance for Industry.’’                approved collections of information                    appropriate automated, electronic,
                                                  The guidance document provides blood                    found in FDA regulations. These                        mechanical, or other technological
                                                  collecting establishments and                           collections of information are subject to              collection techniques or other forms of
                                                  manufacturers of plasma derivatives                     review by the Office of Management and                 information technology.
                                                  with comprehensive recommendations                      Budget (OMB) under the Paperwork                          To Submit Comments and for Further
                                                  intended to minimize the possible risk                  Reduction Act of 1995 (44 U.S.C. 3501–                 Information: To obtain a copy of the
                                                  of transmission of CJD and vCJD from                    3520). The collections of information in               data collection plans and instruments,
                                                  blood and blood products. The guidance                  21 CFR 601.12 have been approved                       submit comments in writing, or request
                                                  is the latest in a series of guidances                  under OMB control number 0910–0338;                    more information on the proposed
                                                  addressing the risk of CJD and vCJD                     the collections of information in 21 CFR               project, contact*: Rebecca Ferrer,
                                                  transmission by blood and blood                         606.100 have been approved under                       Program Director, Basic Biobehavioral
                                                  products.                                               OMB control number 0910–0116; and                      and Psychological Sciences Branch,
                                                     The guidance amends the 2010                         the collections of information in 21 CFR               Behavioral Research Program, Division
                                                  guidance (May 27, 2010; 75 FR 29768)                    600.14 and 606.171 have been approved                  of Cancer Control and Population
mstockstill on DSK4VPTVN1PROD with NOTICES




                                                  and finalizes the 2012 draft guidance                   under OMB control number 0910–0458.                    Sciences, National Cancer Institute,
                                                  (June 11, 2012; 77 FR 34390) by                                                                                9609 Medical Center Dr., Rockville MD
                                                  providing revised labeling                              III. Electronic Access                                 20852. or call non-toll-free number (240)
                                                  recommendations for plasma-derived                         Persons with access to the Internet                 276–6914 or Email your request,
                                                  products, including albumin and                         may obtain the guidance at either                      including your address to: ferrerra@
                                                  products containing plasma-derived                      http://www.fda.gov/BiologicsBlood                      mail.nih.gov. Formal requests for
                                                  albumin. The guidance also provides                     Vaccines/GuidanceCompliance                            additional plans and instruments must
                                                  manufacturers of plasma-derived                         RegulatoryInformation/Guidances/                       be requested in writing.


                                             VerDate Sep<11>2014   16:39 Jan 13, 2016   Jkt 238001   PO 00000   Frm 00022   Fmt 4703   Sfmt 4703   E:\FR\FM\14JAN1.SGM   14JAN1


                                                                                         Federal Register / Vol. 81, No. 9 / Thursday, January 14, 2016 / Notices                                                        1959

                                                    Comment Due Date: Comments                                           communications, the ‘‘active                               effects would yield evidence important
                                                  regarding this information collection are                              ingredient’’ (or mechanisms underlying                     for dissemination, including ways to
                                                  best assured of having their full effect if                            effectiveness) of self-affirmations is                     refine self-affirmation interventions and
                                                  received within 60 days of the date of                                 unknown. Self-affirmation is a potent                      make them more potent, which could
                                                  this publication.                                                      means of augmenting the effectiveness                      change the ways that public health
                                                    Proposed Collection: Self-affirmation                                of threatening health communications.                      messages are constructed. This research
                                                  Construct Validity, 0925–NEW, National                                 Individuals tend to be defensive against                   can inform NCI scientific priorities and
                                                  Cancer Institute (NCI), National                                       information suggesting their behavior                      investments in self-affirmation research.
                                                  Institutes of Health (NIH).                                                                                                       The results of the information collection
                                                    Need and Use of Information                                          puts them at risk for disease or negative
                                                                                                                         health. Previous evidence suggests that                    will be used to further develop and
                                                  Collection: This information collection,
                                                                                                                         self-affirmation may reduce                                improve self-affirmation theory. These
                                                  seeks to refine a theory about how self-
                                                                                                                         defensiveness to threatening health                        findings may allow future researchers to
                                                  competence and values play a role in
                                                  defensive responses to health                                          information, increasing openness to the                    develop and test cancer prevention
                                                  communications. Although                                               message and resulting in increased                         interventions.
                                                  theoretically-driven research has shown                                disease risk perceptions, disease-related                     OMB approval is requested for 3
                                                  that self-affirmation—a process by                                     worry, intentions to engage in                             years. There are no costs to respondents
                                                  which individuals reflect on values that                               preventive behavior, and actual                            other than their time. The total
                                                  are important to them—can improve                                      behavioral change. Understanding the                       estimated annualized burden hours are
                                                  responses to health and cancer                                         mechanisms that explain these robust                       717.
                                                                                                                       ESTIMATED ANNUALIZED BURDEN HOURS
                                                                                                                                                                                   Number of         Average time
                                                                                                                                                                 Number of                                          Total hour
                                                                    Form name                                         Types of respondents                                       responses per       per response
                                                                                                                                                                respondents                                          burden
                                                                                                                                                                                   respondent         (in hours)

                                                  Screener ............................................     General Public ..................................           10,000                 1             1/60           167
                                                  Study .................................................   General Public ..................................            1,100                 1            30/60           550



                                                    Dated: January 7, 2016.                                              DATES:  Written comments should be                         annual cost burden to respondents or
                                                  Karla Bailey,                                                          received on or before March 14, 2016 to                    record keepers from the collection of
                                                  Project Clearance Liaison, National Cancer                             be assured of consideration.                               information (total capital/startup costs
                                                  Institute, NIH.                                                        ADDRESSES: Written comments may be                         and operations and maintenance costs).
                                                  [FR Doc. 2016–00545 Filed 1–13–16; 8:45 am]                            mailed to U.S. Customs and Border                          The comments that are submitted will
                                                  BILLING CODE 4140–01–P                                                 Protection, Attn: Tracey Denning,                          be summarized and included in the CBP
                                                                                                                         Regulations and Rulings, Office of                         request for OMB approval. All
                                                                                                                         International Trade, 90 K Street NE.,                      comments will become a matter of
                                                                                                                         10th Floor, Washington, DC 20229–                          public record. In this document, CBP is
                                                  DEPARTMENT OF HOMELAND
                                                                                                                         1177.                                                      soliciting comments concerning the
                                                  SECURITY
                                                                                                                         FOR FURTHER INFORMATION CONTACT:                           following information collection:
                                                  U.S. Customs and Border Protection                                     Requests for additional information                          Title: Administrative Rulings.
                                                                                                                         should be directed to Tracey Denning,                        OMB Number: 1651–0085.
                                                  [1651–0085]                                                            U.S. Customs and Border Protection,                          Abstract: The collection of
                                                                                                                         Regulations and Rulings, Office of                         information in 19 CFR part 177 is
                                                  Agency Information Collection
                                                                                                                         International Trade, 90 K Street NE.,                      necessary in order to enable Customs
                                                  Activities: Administrative Rulings
                                                                                                                         10th Floor, Washington, DC 20229–                          and Border Protection (CBP) to respond
                                                  AGENCY:  U.S. Customs and Border                                       1177, at 202–325–0265.                                     to requests by importers and other
                                                  Protection, Department of Homeland                                     SUPPLEMENTARY INFORMATION: CBP                             interested persons for the issuance of
                                                  Security                                                               invites the general public and other                       administrative rulings. These rulings
                                                  ACTION: 60-Day notice and request for                                  Federal agencies to comment on                             pertain to the interpretation of
                                                  comments; extension of an existing                                     proposed and/or continuing information                     applicable laws related to prospective
                                                  collection of information.                                             collections pursuant to the Paperwork                      and current transactions involving
                                                                                                                         Reduction Act of 1995 (Pub. L. 104–13).                    classification, marking, and country of
                                                  SUMMARY:   U.S. Customs and Border                                     The comments should address: (a)                           origin. The collection of information in
                                                  Protection (CBP) of the Department of                                  Whether the collection of information is                   Part 177 of the CBP Regulations is also
                                                  Homeland Security will be submitting                                   necessary for the proper performance of                    necessary to enable CBP to make proper
                                                  the following information collection                                   the functions of the agency, including                     decisions regarding the issuance of
                                                  request to the Office of Management and                                whether the information shall have                         binding rulings that modify or revoke
                                                  Budget (OMB) for review and approval                                   practical utility; (b) the accuracy of the                 prior CBP binding rulings. This
                                                                                                                                                                                    collection of information is authorized
mstockstill on DSK4VPTVN1PROD with NOTICES




                                                  in accordance with the Paperwork                                       agency’s estimates of the burden of the
                                                  Reduction Act: Administrative Rulings.                                 collection of information; (c) ways to                     by 19 U.S.C. 66, 1202, (General Note
                                                  CBP is proposing that this information                                 enhance the quality, utility, and clarity                  3(i), Harmonized Tariff Schedule of the
                                                  collection be extended with a change to                                of the information to be collected; (d)                    United States). The application to obtain
                                                  the burden hours but no change to the                                  ways to minimize the burden including                      an administrative ruling is accessible at:
                                                  information required. This document is                                 the use of automated collection                            https://apps.cbp.gov/erulings.
                                                  published to obtain comments from the                                  techniques or the use of other forms of                      Action: CBP proposes to extend the
                                                  public and affected agencies.                                          information technology; and (e) the                        expiration date of this information


                                             VerDate Sep<11>2014        18:58 Jan 13, 2016        Jkt 238001     PO 00000      Frm 00023     Fmt 4703     Sfmt 4703   E:\FR\FM\14JAN1.SGM   14JAN1



Document Created: 2016-01-14 02:50:28
Document Modified: 2016-01-14 02:50:28
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesComments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication.
FR Citation81 FR 1958 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR